179 related articles for article (PubMed ID: 24317794)
41. Gly482Ser polymorphism in the peroxisome proliferator-activated receptor gamma coactivator-1alpha gene is associated with oxidative stress and abdominal obesity.
Weng SW; Lin TK; Wang PW; Chen IY; Lee HC; Chen SD; Chuang YC; Liou CW
Metabolism; 2010 Apr; 59(4):581-6. PubMed ID: 19913841
[TBL] [Abstract][Full Text] [Related]
42. [Gly482Ser polymorphism of the coactivator-1alpha of the activated receptor of peroxisome gamma proliferation in individuals from Maracaibo, Venezuela].
Zambrano M; Fernández E; López M; Rangel A; de Romero P; Fernández V; Marina Morales L; Molero-Conejo E; Connell L; Raleigh X; Aranguren-Mendez J
Invest Clin; 2009 Sep; 50(3):285-94. PubMed ID: 19961051
[TBL] [Abstract][Full Text] [Related]
43. Linking Metabolic Disease With the PGC-1α Gly482Ser Polymorphism.
Vandenbeek R; Khan NP; Estall JL
Endocrinology; 2018 Feb; 159(2):853-865. PubMed ID: 29186342
[TBL] [Abstract][Full Text] [Related]
44. Lack of direct evidence for natural selection at the candidate thrifty gene locus, PPARGC1A.
Cadzow M; Merriman TR; Boocock J; Dalbeth N; Stamp LK; Black MA; Visscher PM; Wilcox PL
BMC Med Genet; 2016 Nov; 17(1):80. PubMed ID: 27846814
[TBL] [Abstract][Full Text] [Related]
45. Unraveling Gut Microbiota Signatures Associated with PPARD and PARGC1A Genetic Polymorphisms in a Healthy Population.
Bailén M; Tabone M; Bressa C; Lominchar MGM; Larrosa M; González-Soltero R
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205333
[TBL] [Abstract][Full Text] [Related]
46. Association of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PPARGC1A) gene polymorphisms and type 2 diabetes mellitus: a meta-analysis.
Yang Y; Mo X; Chen S; Lu X; Gu D
Diabetes Metab Res Rev; 2011 Feb; 27(2):177-84. PubMed ID: 21294239
[TBL] [Abstract][Full Text] [Related]
47. Testing the thrifty gene hypothesis: the Gly482Ser variant in PPARGC1A is associated with BMI in Tongans.
Myles S; Lea RA; Ohashi J; Chambers GK; Weiss JG; Hardouin E; Engelken J; Macartney-Coxson DP; Eccles DA; Naka I; Kimura R; Inaoka T; Matsumura Y; Stoneking M
BMC Med Genet; 2011 Jan; 12():10. PubMed ID: 21244673
[TBL] [Abstract][Full Text] [Related]
48. Variation in PPARG is associated with longitudinal change in insulin resistance in Mexican Americans at risk for type 2 diabetes.
Black MH; Wu J; Takayanagi M; Wang N; Taylor KD; Haritunians T; Trigo E; Lawrence JM; Watanabe RM; Buchanan TA; Xiang AH
J Clin Endocrinol Metab; 2015 Mar; 100(3):1187-95. PubMed ID: 25584717
[TBL] [Abstract][Full Text] [Related]
49. Comprehensive Analysis of Established Dyslipidemia-Associated Loci in the Diabetes Prevention Program.
Varga TV; Winters AH; Jablonski KA; Horton ES; Khare-Ranade P; Knowler WC; Marcovina SM; Renström F; Watson KE; Goldberg R; Florez JC; Pollin TI; Franks PW
Circ Cardiovasc Genet; 2016 Dec; 9(6):495-503. PubMed ID: 27784733
[TBL] [Abstract][Full Text] [Related]
50. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
[TBL] [Abstract][Full Text] [Related]
51. The Gly482Ser genotype at the PPARGC1A gene and elevated blood pressure: a meta-analysis involving 13,949 individuals.
Vimaleswaran KS; Luan J; Andersen G; Muller YL; Wheeler E; Brito EC; O'Rahilly S; Pedersen O; Baier LJ; Knowler WC; Barroso I; Wareham NJ; Loos RJ; Franks PW
J Appl Physiol (1985); 2008 Oct; 105(4):1352-8. PubMed ID: 18467552
[TBL] [Abstract][Full Text] [Related]
52. Peroxisome proliferator-activated receptor gamma coactivator 1α variation: a closer look at obesity onset age and its related metabolic status and body composition.
Zamaninour N; Mirzaei K; Maghbooli Z; Keshavarz SA
Appl Physiol Nutr Metab; 2018 Dec; 43(12):1321-1325. PubMed ID: 29879371
[TBL] [Abstract][Full Text] [Related]
53. DNA sequence variants in PPARGC1A, a gene encoding a coactivator of the ω-3 LCPUFA sensing PPAR-RXR transcription complex, are associated with NV AMD and AMD-associated loci in genes of complement and VEGF signaling pathways.
SanGiovanni JP; Chen J; Sapieha P; Aderman CM; Stahl A; Clemons TE; Chew EY; Smith LE
PLoS One; 2013; 8(1):e53155. PubMed ID: 23335958
[TBL] [Abstract][Full Text] [Related]
54. Association between PPARGC1A single nucleotide polymorphisms and increased risk of nonalcoholic fatty liver disease among Iranian patients with type 2 diabetes mellitus.
Saremi L; Lotfıpanah S; Mohammadi M; Hosseinzadeh H; Hosseini-Khah Z; Johari B; Saltanatpour Z
Turk J Med Sci; 2019 Aug; 49(4):1089-1094. PubMed ID: 31390852
[TBL] [Abstract][Full Text] [Related]
55. Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.
Tai CM; Huang CK; Tu HP; Hwang JC; Yeh ML; Huang CF; Huang JF; Dai CY; Chuang WL; Yu ML
Medicine (Baltimore); 2016 Mar; 95(12):e3120. PubMed ID: 27015186
[TBL] [Abstract][Full Text] [Related]
56. Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner.
Brøns C; Jacobsen S; Nilsson E; Rönn T; Jensen CB; Storgaard H; Poulsen P; Groop L; Ling C; Astrup A; Vaag A
J Clin Endocrinol Metab; 2010 Jun; 95(6):3048-56. PubMed ID: 20410232
[TBL] [Abstract][Full Text] [Related]
57. PPARGC1A DNA methylation in subcutaneous adipose tissue in low birth weight subjects--impact of 5 days of high-fat overfeeding.
Gillberg L; Jacobsen SC; Rönn T; Brøns C; Vaag A
Metabolism; 2014 Feb; 63(2):263-71. PubMed ID: 24262291
[TBL] [Abstract][Full Text] [Related]
58. Quantitative trait loci, G×E and G×G for glycemic traits: response to metformin and placebo in the Diabetes Prevention Program (DPP).
Maxwell TJ; Franks PW; Kahn SE; Knowler WC; Mather KJ; Florez JC; Jablonski KA;
J Hum Genet; 2022 Aug; 67(8):465-473. PubMed ID: 35260800
[TBL] [Abstract][Full Text] [Related]
59. Whole exome sequencing identifies variation in CYB5A and RNF10 associated with adiposity and type 2 diabetes.
Huang K; Nair AK; Muller YL; Piaggi P; Bian L; Del Rosario M; Knowler WC; Kobes S; Hanson RL; Bogardus C; Baier LJ
Obesity (Silver Spring); 2014 Apr; 22(4):984-8. PubMed ID: 24151200
[TBL] [Abstract][Full Text] [Related]
60.
Yvert T; Miyamoto-Mikami E; Tobina T; Shiose K; Kakigi R; Tsuzuki T; Takaragawa M; Ichinoseki-Sekine N; Pérez M; Kobayashi H; Tanaka H; Naito H; Fuku N
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32867330
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
